Merck has reported results for fourth quarter ended December 31, 2011.
The company has posted a rise of 175.22% in its net profit at Rs 12.66 crore for the quarter ended December 31, 2011 as compared to Rs 4.60 crore for the same quarter in the previous year. Total income has decreased by 1.21% at Rs 127.12 crore for the quarter under review as compared to Rs 128.68 crore in the same quarter of 2010.
Merck is a global pharmaceutical and chemical enterprise. In the pharmaceutical segment major products include vitamins, nutritional supplement, cardio vascular, respiratory, hematinics, cough and cold, non-steroidal anti-inflammatory (NSAID), antibiotics, oral rehydration salts and encephalotropics.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1858.70 |
Dr. Reddys Lab | 1258.55 |
Cipla | 1559.20 |
Lupin | 2198.25 |
Zydus Lifesciences | 1004.00 |
View more.. |